1. Home
  2. SMLR vs BGH Comparison

SMLR vs BGH Comparison

Compare SMLR & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMLR
  • BGH
  • Stock Information
  • Founded
  • SMLR 2007
  • BGH 2012
  • Country
  • SMLR United States
  • BGH United States
  • Employees
  • SMLR N/A
  • BGH N/A
  • Industry
  • SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BGH Investment Managers
  • Sector
  • SMLR Health Care
  • BGH Finance
  • Exchange
  • SMLR Nasdaq
  • BGH Nasdaq
  • Market Cap
  • SMLR 289.5M
  • BGH 308.6M
  • IPO Year
  • SMLR 2014
  • BGH N/A
  • Fundamental
  • Price
  • SMLR $63.63
  • BGH $16.22
  • Analyst Decision
  • SMLR
  • BGH
  • Analyst Count
  • SMLR 0
  • BGH 0
  • Target Price
  • SMLR N/A
  • BGH N/A
  • AVG Volume (30 Days)
  • SMLR 1.1M
  • BGH 61.5K
  • Earning Date
  • SMLR 11-04-2024
  • BGH 01-01-0001
  • Dividend Yield
  • SMLR N/A
  • BGH 10.06%
  • EPS Growth
  • SMLR N/A
  • BGH N/A
  • EPS
  • SMLR 2.04
  • BGH N/A
  • Revenue
  • SMLR $58,938,000.00
  • BGH N/A
  • Revenue This Year
  • SMLR N/A
  • BGH N/A
  • Revenue Next Year
  • SMLR N/A
  • BGH N/A
  • P/E Ratio
  • SMLR $29.79
  • BGH N/A
  • Revenue Growth
  • SMLR N/A
  • BGH N/A
  • 52 Week Low
  • SMLR $20.88
  • BGH $11.92
  • 52 Week High
  • SMLR $79.45
  • BGH $14.50
  • Technical
  • Relative Strength Index (RSI)
  • SMLR 64.88
  • BGH 70.36
  • Support Level
  • SMLR $56.75
  • BGH $15.60
  • Resistance Level
  • SMLR $63.29
  • BGH $16.30
  • Average True Range (ATR)
  • SMLR 8.83
  • BGH 0.19
  • MACD
  • SMLR 0.32
  • BGH 0.06
  • Stochastic Oscillator
  • SMLR 56.40
  • BGH 100.00

About SMLR Semler Scientific Inc.

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.

Share on Social Networks: